New Classifications of Five Distinct “Sleep” Profi... ...
A Professional Overview of Hypertension ...
High-speed imaging tracks live brain cell activity...
Drug candidate slows motor neuron disease progress...
Drug candidate slows motor neuron disease progress...
Mark Cuban: A Master Disrupter for American Health...
Superbugs on your plate: How antimicrobial resistance spread...
June 13,2026
Can marijuana cause lung cancer?...
June 12,2026
Standard depression screening could be missing key symptoms ...
June 11,2026
More women are having babies later in life. How to improve y...
June 10,2026
For severe babesiosis, red blood cell exchange is associated...
June 09,2026
Cause or effect? Study answers question about gene linked wi...
June 08,2026
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Today's News
Eye Infections (Updated) | Clinical Medicine...
Announcement of the 2025 Nobel Prize in ...
Dr. Fauci among hundreds who've contract...
Why are young, healthy adults experienci...
Reprogramming Stem Cells Could Cure Type...
More News
Targeting treatment resistance in chronic lymphocytic leukemia with a compound that goes beyond current BTK inhibitors

Targeting treatment resistance in chronic lymphocytic leukemia with a compound that goes beyond current BTK inhibitors

by University of Miami Leonard M. Miller School of MedicineCredit: Unsplash/CC0 Public DomainNew research from Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Me
Oncology June 11,2024
Targeting treatment resistance in chronic lymphocytic leukemia with a compound that goes beyond current BTK inhibitors

Targeting treatment resistance in chronic lymphocytic leukemia with a compound that goes beyond current BTK inhibitors

by University of Miami Leonard M. Miller School of MedicineCredit: Unsplash/CC0 Public DomainNew research from Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Me
Oncology June 11,2024
A new drug candidate can shrink kidney cysts

A new drug candidate can shrink kidney cysts

by Anne Trafton,Massachusetts Institute of TechnologyThe cysts that appear in ADPKD cause kidneys to enlarge until they no longer function properly (center image). At the right is a kidney follo
Nephrology & Urology June 11,2024
A new drug candidate can shrink kidney cysts

A new drug candidate can shrink kidney cysts

by Anne Trafton,Massachusetts Institute of TechnologyThe cysts that appear in ADPKD cause kidneys to enlarge until they no longer function properly (center image). At the right is a kidney follo
Nephrology & Urology June 11,2024
Restoring normal sleep reduces amyloid-beta accumulation in mouse model of Alzheimer's disease

Restoring normal sleep reduces amyloid-beta accumulation in mouse model of Alzheimer's disease

by Baylor College of MedicineThe white line represents a hypnogram that indicates what state the brain is in during your sleeping time: active wake, quiet wake, rapid eye movement (REM) sleep, or
Neurology June 11,2024
Restoring normal sleep reduces amyloid-beta accumulation in mouse model of Alzheimer's disease

Restoring normal sleep reduces amyloid-beta accumulation in mouse model of Alzheimer's disease

by Baylor College of MedicineThe white line represents a hypnogram that indicates what state the brain is in during your sleeping time: active wake, quiet wake, rapid eye movement (REM) sleep, or
Neurology June 11,2024
Mixed-ancestry genetic research shows a bit of Native American DNA could reduce risk of Alzheimer's disease

Mixed-ancestry genetic research shows a bit of Native American DNA could reduce risk of Alzheimer's disease

by Diane Xue and Hanley Kingston,The ConversationTraditionally, researchers search for individual genes that are related to disease risk by looking at tiny genetic markers all across the genome.
Neurology June 11,2024
Mixed-ancestry genetic research shows a bit of Native American DNA could reduce risk of Alzheimer's disease

Mixed-ancestry genetic research shows a bit of Native American DNA could reduce risk of Alzheimer's disease

by Diane Xue and Hanley Kingston,The ConversationTraditionally, researchers search for individual genes that are related to disease risk by looking at tiny genetic markers all across the genome.
Neurology June 11,2024
Neuropathology tied to dementia ID'd in football players who had CTE

Neuropathology tied to dementia ID'd in football players who had CTE

(HealthDay)—White matter rarefaction, arteriolosclerosis, and dorsolateral frontal cortex (DLFC) neurofibrillary tangles (NFTs) are independently associated with dementia among older men who played fo
Neurology June 11,2024
Neuropathology tied to dementia ID'd in football players who had CTE

Neuropathology tied to dementia ID'd in football players who had CTE

(HealthDay)—White matter rarefaction, arteriolosclerosis, and dorsolateral frontal cortex (DLFC) neurofibrillary tangles (NFTs) are independently associated with dementia among older men who played fo
Neurology June 11,2024
Older adults with dementia but without close family: Who are they? And who cares for them?

Older adults with dementia but without close family: Who are they? And who cares for them?

by Janelle Taylor,The ConversationCredit: AI-generated imageWhat happens toolder adults who do not have close familywhen they developdementia? The truth is, we hardly know.Popu
Neurology June 11,2024
Older adults with dementia but without close family: Who are they? And who cares for them?

Older adults with dementia but without close family: Who are they? And who cares for them?

by Janelle Taylor,The ConversationCredit: AI-generated imageWhat happens toolder adults who do not have close familywhen they developdementia? The truth is, we hardly know.Popu
Neurology June 11,2024
Rejuvenated immune cells can improve clearance of toxic waste from brain

Rejuvenated immune cells can improve clearance of toxic waste from brain

by Washington University School of MedicinePBMs are distinct from microglia and sample CSF and ISF.a, CD206+ PBMs (cyan) are easily distinguishable from IBA1+ microglia (yellow) and are loc
Neurology June 11,2024
Rejuvenated immune cells can improve clearance of toxic waste from brain

Rejuvenated immune cells can improve clearance of toxic waste from brain

by Washington University School of MedicinePBMs are distinct from microglia and sample CSF and ISF.a, CD206+ PBMs (cyan) are easily distinguishable from IBA1+ microglia (yellow) and are loc
Neurology June 11,2024
What it's really like to live with dementia

What it's really like to live with dementia

by Catherine Bailey Et Al,The ConversationBeing around family and friends is important. Credit: PexelsMore than225,000 people develop dementiaevery year – that's roughly one pers
Neurology June 11,2024
What it's really like to live with dementia

What it's really like to live with dementia

by Catherine Bailey Et Al,The ConversationBeing around family and friends is important. Credit: PexelsMore than225,000 people develop dementiaevery year – that's roughly one pers
Neurology June 11,2024
People with depression, anxiety may develop Alzheimer's at younger age

People with depression, anxiety may develop Alzheimer's at younger age

by American Academy of NeurologyCredit: CC0 Public DomainHaving depression is known to increase your risk for developing Alzheimer's disease. Now a new, preliminary study released today, Febr
Neurology June 11,2024
People with depression, anxiety may develop Alzheimer's at younger age

People with depression, anxiety may develop Alzheimer's at younger age

by American Academy of NeurologyCredit: CC0 Public DomainHaving depression is known to increase your risk for developing Alzheimer's disease. Now a new, preliminary study released today, Febr
Neurology June 11,2024
Older people with early, asymptomatic Alzheimer's at risk of falls

Older people with early, asymptomatic Alzheimer's at risk of falls

by Tamara Bhandari,Washington University School of MedicineCredit: CC0 Public DomainFalls are the leading cause of fatal injuries in older adults, causing more than 800,000 hospitalizations and
Neurology June 11,2024
Older people with early, asymptomatic Alzheimer's at risk of falls

Older people with early, asymptomatic Alzheimer's at risk of falls

by Tamara Bhandari,Washington University School of MedicineCredit: CC0 Public DomainFalls are the leading cause of fatal injuries in older adults, causing more than 800,000 hospitalizations and
Neurology June 11,2024
More News
Week’s Top
Podcasts
... Preparing for a tough exam? A tough gym workout could help with your studies ... ... GOSH BRC Showcase 2025 - Genomic medicine ... ... Brain activity goes to extremes in soccer fans, neuroimaging reveals ...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com